Aptose Biosciences Inc (APTO)
1.20
+0.01
(+0.84%)
USD |
NASDAQ |
May 03, 16:00
1.21
+0.01
(+0.83%)
After-Hours: 20:00
Aptose Biosciences 1 Year Total Returns (Daily): -84.88% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -84.88% |
May 02, 2024 | -85.58% |
May 01, 2024 | -85.33% |
April 30, 2024 | -83.43% |
April 29, 2024 | -83.01% |
April 26, 2024 | -82.83% |
April 25, 2024 | -83.89% |
April 24, 2024 | -83.12% |
April 23, 2024 | -83.09% |
April 22, 2024 | -83.09% |
April 19, 2024 | -83.59% |
April 18, 2024 | -83.25% |
April 17, 2024 | -83.53% |
April 16, 2024 | -83.47% |
April 15, 2024 | -83.07% |
April 12, 2024 | -82.74% |
April 11, 2024 | -82.97% |
April 10, 2024 | -83.27% |
April 09, 2024 | -82.91% |
April 08, 2024 | -82.18% |
April 05, 2024 | -84.67% |
April 04, 2024 | -84.44% |
April 03, 2024 | -85.00% |
April 02, 2024 | -83.54% |
April 01, 2024 | -83.33% |
Date | Value |
---|---|
March 28, 2024 | -82.47% |
March 27, 2024 | -84.54% |
March 26, 2024 | -83.44% |
March 25, 2024 | -84.37% |
March 22, 2024 | -82.34% |
March 21, 2024 | -82.26% |
March 20, 2024 | -82.73% |
March 19, 2024 | -81.20% |
March 18, 2024 | -81.20% |
March 15, 2024 | -82.53% |
March 14, 2024 | -83.95% |
March 13, 2024 | -82.18% |
March 12, 2024 | -81.12% |
March 11, 2024 | -80.12% |
March 08, 2024 | -80.66% |
March 07, 2024 | -80.01% |
March 06, 2024 | -80.26% |
March 05, 2024 | -79.77% |
March 04, 2024 | -79.20% |
March 01, 2024 | -78.72% |
February 29, 2024 | -79.38% |
February 28, 2024 | -78.81% |
February 27, 2024 | -79.45% |
February 26, 2024 | -80.21% |
February 23, 2024 | -81.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.58%
Minimum
May 02 2024
403.1%
Maximum
Mar 06 2020
-5.17%
Average
-50.59%
Median
Mar 13 2023
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |